SKI Market

Indian Indices

Nifty

24,971.90 -140.50
(-0.56%)

Sensex

81,896.79 -511.38
( -0.62%)

Bank Nifty

56,059.35 -193.50
( -0.34%)

Nifty IT

38,414.10 -577.35
( -1.48%)

Global Indices

Nasdaq

42,233.20 40.53
(0.10%)

Dow Jones

5,989.55 -12.32
(-0.21%)

Hang Seng

38,330.35 -72.88
(-0.19%)

Nikkei 225

8,774.65 -17.15
(-0.20%)

Forex

USD-INR

86.67 0.24
(0.27%)

EUR-INR

99.45 0.06
(0.06%)

GBP-INR

116.39 0.20
(0.17%)

JPY-INR

0.60 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Beta Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

535022

INE351Y01019

127.8259206

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BETA

95.48

1790.77

EPS(TTM)

Face Value()

Div & Yield %

18.58

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	0.00	1.50	1.26	0.69	0.92	2.32
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	1.50	1.26	0.69	0.92	2.32
Other Income	0.28	0.86	6.10	115.16	819.60	1847.26
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.28	2.36	7.36	115.85	820.52	1849.58
EXPENDITURE :
Raw Materials	0.00	0.00	0.00	0.00	0.00	0.00
Power & Fuel Cost	0.01	0.07	0.05	0.12	0.14	0.23
Employee Cost	0.76	1.45	1.46	1.78	2.55	3.48
Other Manufacturing Expenses	0.03	0.19	0.18	0.17	0.32	0.49
Selling & Administrative Expenses	1.24	1.96	2.51	2.36	5.09	6.14
Miscellaneous Expenses	4.08	92.29	0.42	111.11	807.24	3450.80
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	6.12	95.97	4.62	115.54	815.33	3461.14
Operating Profit	-5.84	-93.61	2.74	0.30	5.19	-1611.55
Interest	0.00	3.62	3.36	3.11	2.90	2.69
Gross Profit	-5.84	-97.23	-0.62	-2.81	2.29	-1614.24
Depreciation	0.00	0.16	0.26	0.36	0.42	0.74
Profit Before Tax	-5.84	-97.39	-0.88	-3.17	1.87	-1614.98
Tax	0.00	0.00	0.00	0.00	-0.02	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	104.71	158.80
Reported Net Profit	-5.84	-97.39	-0.88	-3.17	-102.83	-1773.79
Extraordinary Items	-0.14	-91.71	0.01	0.87	195.12	-1453.54
Adjusted Net Profit	-5.70	-5.68	-0.89	-4.04	-297.95	-320.25
Adjustment below Net Profit	-0.17	-0.03	0.13	-0.05	0.22	-0.16
P & L Balance brought forward	-418.98	-1149.42	-1148.67	-1145.45	-1042.91	249.84
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	-827.86	0.00	0.00	-0.07	-481.19
P & L Balance carried down	-425.00	-418.98	-1149.42	-1148.67	-1145.45	-1042.91
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-1.86	-31.03	-0.28	-1.01	-32.76	-565.17
Earnings Per Share(Adj)-Unit Curr	-1.86	-31.03	-0.28	-1.01	-32.76	-565.17
Book Value-Unit Curr	-61.51	-59.60	-28.56	-11.78	24.23	311.92
Book Value(Adj)-Unit Curr	-61.51	-59.60	-28.56	-11.78	24.23	311.92

24,971.90 -140.50 (-0.56%)

81,896.79 -511.38 ( -0.62%)

56,059.35 -193.50 ( -0.34%)

38,414.10 -577.35 ( -1.48%)

42,233.20 40.53 (0.10%)

5,989.55 -12.32 (-0.21%)

38,330.35 -72.88 (-0.19%)

8,774.65 -17.15 (-0.20%)

86.67 0.24 (0.27%)

99.45 0.06 (0.06%)

116.39 0.20 (0.17%)

0.60 0.00 (-0.02%)